These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29910670)

  • 1. ICOS signal facilitates Foxp3 transcription to favor suppressive function of regulatory T cells.
    Chen Q; Mo L; Cai X; Wei L; Xie Z; Li H; Li J; Hu Z
    Int J Med Sci; 2018; 15(7):666-673. PubMed ID: 29910670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice.
    Kornete M; Sgouroudis E; Piccirillo CA
    J Immunol; 2012 Feb; 188(3):1064-74. PubMed ID: 22227569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4
    Chauhan R; Awasthi V; Thakur RS; Pande V; Chattopadhyay D; Das J
    Malar J; 2022 Feb; 21(1):32. PubMed ID: 35109868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.
    Conrad C; Gregorio J; Wang YH; Ito T; Meller S; Hanabuchi S; Anderson S; Atkinson N; Ramirez PT; Liu YJ; Freedman R; Gilliet M
    Cancer Res; 2012 Oct; 72(20):5240-9. PubMed ID: 22850422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance.
    Busse M; Krech M; Meyer-Bahlburg A; Hennig C; Hansen G
    J Immunol; 2012 Aug; 189(4):1975-82. PubMed ID: 22815292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid attenuates acute heart rejection by increasing regulatory T cell and repressing differentiation of Th17 cell in the presence of TGF-β.
    Wang G; Zhong A; Wang S; Dong N; Sun Z; Xia J
    Transpl Int; 2010 Oct; 23(10):986-97. PubMed ID: 20412539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis.
    Lu LC; Deantonio C; Palu CC; Lee YH; Mitchell LS; Cowan M; Corser M; Sherry L; Cheng AL; Quaratino S; Shao YY; Sainson RCA; Hsu CH
    Oncology; 2022; 100(8):419-428. PubMed ID: 35709702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.
    Sim GC; Martin-Orozco N; Jin L; Yang Y; Wu S; Washington E; Sanders D; Lacey C; Wang Y; Vence L; Hwu P; Radvanyi L
    J Clin Invest; 2014 Jan; 124(1):99-110. PubMed ID: 24292706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection.
    Abel S; Lückheide N; Westendorf AM; Geffers R; Roers A; Müller W; Sparwasser T; Matuschewski K; Buer J; Hansen W
    J Immunol; 2012 Jun; 188(11):5467-77. PubMed ID: 22544931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
    J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of
    Landuyt AE; Klocke BJ; Colvin TB; Schoeb TR; Maynard CL
    J Immunol; 2019 Feb; 202(4):1039-1044. PubMed ID: 30642977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse Sertoli cells sustain de novo generation of regulatory T cells by triggering the notch pathway through soluble JAGGED1.
    Campese AF; Grazioli P; de Cesaris P; Riccioli A; Bellavia D; Pelullo M; Padula F; Noce C; Verkhovskaia S; Filippini A; Latella G; Screpanti I; Ziparo E; Starace D
    Biol Reprod; 2014 Mar; 90(3):53. PubMed ID: 24478388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection.
    Redpath SA; van der Werf N; Cervera AM; MacDonald AS; Gray D; Maizels RM; Taylor MD
    Eur J Immunol; 2013 Mar; 43(3):705-15. PubMed ID: 23319295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Lozano T; Villanueva L; Durántez M; Gorraiz M; Ruiz M; Belsúe V; Riezu-Boj JI; Hervás-Stubbs S; Oyarzábal J; Bandukwala H; Lourenço AR; Coffer PJ; Sarobe P; Prieto J; Casares N; Lasarte JJ
    J Immunol; 2015 Oct; 195(7):3180-9. PubMed ID: 26324768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 and ICOS Antagonize Bim and Promote Regulatory T Cell Accrual with Age.
    Raynor J; Karns R; Almanan M; Li KP; Divanovic S; Chougnet CA; Hildeman DA
    J Immunol; 2015 Aug; 195(3):944-52. PubMed ID: 26109645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
    Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
    Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.